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ABSTRACT
Background: Cholangiocellular carcinoma is a malignant tumor that occurs mainly in elderly dogs and cats. Primary 
hepatobiliary neoplasms are considered rare in felines, although cholangiocarcinoma is the most common tumor type 
among malignant liver tumors in the species. The objective of this work is to report two cases of cholangiocarcinoma in 
young domestic cats, with three years old, and to approach clinical and pathological aspects to promote awareness of this 
type of injury in young animals, with a focus on prevention of predisposing factors.
Cases: A 3-year-old male domestic cat (cat 1) had a history of progressive weight loss, persistent vomiting, diarrhea, 
and episodes of seizure. At the clinical examination was noted moderate degree of jaundice. In the biochemical exams it 
was verified as alteration hypoproteinemia, increase of urea and hyponatremia. Abdominal ultrasonography revealed a 
formation in the left epigastric region measuring 8.0 x 5.0 cm, with a diffusely heterogeneous parenchyma, suggestive of 
hepatic neoplasia, in addition to the presence of free abdominal fluid. Cavity fluid analysis was suggestive of carcinoma. 
A 3-year-old male domestic cat (cat 2), with history of hyporexia, emaciation and vomiting was taken to care. Physical 
examination showed moderate dehydration, hypocorous mucosa and presence of abdominal mass on palpation. The ani-
mal’s serum biochemical assessment were verified as changes, increasing AST. Ultrasonographic examination showed 
an abdominal mass, located caudally to the spleen, with irregular shape, measuring approximately 4.7 cm suggestive of 
hepatic neoplasia, in addition to the presence of abdominal fluid. The hepatic cytology performed by fine needle aspira-
tion was suggestive of carcinoma. After the clinical worsening of two cats and due unfavorable prognosis, euthanasia and 
necropsy were performed. In the macroscopic analysis of cat 1, numerous nodules of whitish and sometimes “umbilicate” 
coloration were observed in the liver, measuring up to three cm in diameter, distributed randomly by the hepatic paren-
chyma and with a soft consistency at cut. An ovoid-wicking mass, measuring 6.0 x 7.0 x 5.0 cm and coloring ranging 
from white to light brown was checked in omentum. In the macroscopic evaluation of cat 2, numerous coalescing masses 
of whitish coloring measuring up to 6.0 cm in diameter were observed covering almost every hepatic parenchyma and 
also affecting the pancreas, with a soft consistency at cut. The microscopic findings of both cats were compatible with the 
diagnosis of cholangiocarcinoma. Considering the immunohistochemical profile, in both cases there was positivity for the 
CK Pan antibody and CEA and negativity for the CK20, TTF-1, Hepatocyte specific antigen, CD10 and CD56 antibodies.
Discussion: Cholangiocarcinomas usually occur in elderly animals, with a mean age of 9 years, so it may be suggested 
that the cause of the disease in cat 1 and 2 was possibly related to the early and continuous presence of carcinogens. The 
biliary duct trematod Platynosomum fastosum, the chemical agents plutonium and americium, intestinal parasites such 
as Ancylostoma spp. and Trichuris vulpis, as well as the occurrence of chronic inflammations independent of etiology 
are commonly involved in the occurrence of cholangiocarcinoma. Clinical and anatomopathological observations made 
evident that these two young cats, with three years old, had metastatic cholangiocarcinoma. Thus, veterinary providers 
should be aware that this tumor type can occur in young animals and is mindful of means of prevention and / or recom-
mended treatment of predisposing factors.
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INTRODUCTION
Cholangiocarcinoma are malignant neoplas-
ms that primarily originate from the intrahepatic or 
extrahepatic areas or gallbladder. This tumor type, 
although widely reported in animal species such 
as canines, felines, cattle, horses, sheep, and goats, 
occurs mainly in senior dogs and cats [7]. Primary 
hepatobiliary tumors are considered rare in cats, with 
prevalence ranging from 1.5% to 2.3% among neo-
plasms in felines. Bile duct tumors are predominant 
when compared with hepatocellular tumors and thus 
constitute the most common type of malignant hepatic 
neoplasms in cats [8,11]. The clinical signs of injury 
are considered non-specific, and the causes of cho-
langiocarcinoma are not defined in domestic animals. 
Some risk factors are predisposing, such as bile and 
intestinal parasitosis, exposure to chemical agents, and 
chronic inflammation [6,7]. Cholangiocellular carci-
nomas are considered intractable due to the potential 
of dissemination, migration, and progression. Thus, 
surgical intervention is rarely employed because of 
the risk of death and relapses and the chemotherapy 
is generally ineffective [6,8]. 
The objective of this work is to report two 
cases of cholangiocarcinoma in young domestic cats, 
with three years old, and to approach clinical and pa-
thological aspects to promote awareness of this type 
of injury in young animals, with a focus on prevention 
of predisposing factors.
CASES
Cat 1. A 3-year-old male of undefined breed 
treated at a private clinic in Rio de Janeiro, Brazil. 
He had a history of progressive weight loss, persis-
tent vomiting, diarrhea, and seizure episodes. During 
examination, was noticed a moderate degree of jaun-
dice. Serum biochemistry revealed the following: 
hypoproteinemia, 4.8 mg/dL (reference values, 5.4 to 
7.8 mg/dL); high urea, 97.9 mg/dL (reference values, 
30.0 to 60.0 mg/dL); and hyponatremia, 130.0 mEq/L 
(reference values, 140.0 to 150.0 mEq/L). Abdo-
minal ultrasonography showed a formation in the 
left epigastric region measuring 8.0 × 5.0 cm, with 
diffusely heterogeneous parenchyma, suggestive 
of hepatic neoplasia and abdominal effusion. The 
abdominal cavity fluid had a cloudy appearance and 
pink coloration, and red blood cells, non-degenerated 
neutrophils, activated macrophages, lymphocytes, 
and rare plasma cells were present. There were also 
different cell shapes, varying from rounded to oval, 
with discrete anisocytosis and anisokaryosis.
Cat 2. Also a 3-year-old male of undefined 
breed treated at the Medical Clinic of Domestic Cats 
in the Veterinary Hospital of Small Animals of the 
Federal Rural University of Rio de Janeiro (UFRRJ). 
He had a history of hyporexia, weight loss, and vo-
miting. Physical examination of the patient indicated 
moderate dehydration, pale mucosa, and the presence 
of an abdominal mass upon palpation. Biochemical 
evaluation showed an increase in aspartate aminotrans-
ferase (AST) levels (290 U/L; reference values, 5.0 
to 60 U/L). Ultrasound revealed an abdominal mass 
located caudally to the spleen with an irregular shape 
and measuring approximately 4.7 cm; this observation 
suggested hepatic neoplasm. In addition, abdominal 
fluid was present. The cytology hepatic was performed 
via fine needle puncture guided by ultrasonography, 
where the presence of epithelial cells with moderate 
cellularity, arranged in groups, with moderate pleo-
morphism, basaloid appearance, and anisocytosis was 
noted. The cytoplasm of these cells had well-defined 
limits and bluish coloration. The nucleus had moderate 
pleomorphism, anisokaryosis, multinucleation, multi-
ple nucleoli, and moderately coarse chromatin. There 
were also inflammatory cells with the predominance 
of neutrophils, mononuclear cells, activated macro-
phages, and a moderate amount of red blood cells. The 
cytological analysis suggested carcinoma. 
Cats 1 and 2 were both negative for feline 
leukemia and feline immunodeficiency viruses. In two 
cases, the initial treatment recommended the control of 
emesis and support care. After clinical worsening and 
due unfavorable prognosis, euthanasia and necropsies 
were performed for both cats. 
In cat 1, numerous, umbilicated nodules of 
whitish color were observed in the liver, measuring 
up to 3.0 cm in diameter and distributed randomly by 
the parenchyma (Figure 1A), with a soft consistency 
at the cut. A mass involving the omentum, measuring 
6.0 × 7.0 × 5.0 cm and coloring varying from white 
to light brown, was also checked. In cat 2, numerous 
coalescing masses of whitish coloring measuring up 
to 6.0 cm in diameter were observed covering almost 
every hepatic parenchyma (Figure 1B), which also 
affected the pancreas, with a soft consistency at the cut.
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For both patients, organ fragments were col-
lected, fixed in 10% formalin, and sent to the UFRRJ 
Pathology Department for histopathological analysis. 
Specimens were cleaved, processed, and submitted 
for hematoxylin and eosin (HE) staining and micros-
copic evaluation.
Histopathological examination of both animals 
revealed diffuse and marked proliferation of neoplastic 
cells of epithelial origin, arranged in a tubular form, in 
the hepatic tissue. Cellular pleomorphism, anisocyto-
sis, anisokaryosis, eosinophilic cytoplasm, nuclei with 
coarse chromatin, multiple nucleoli, and high mitotic 
activity were also observed (Figure 2A and Figure 
2B). Bands of connective tissue were observed around 
cellular proliferation, sometimes forming nodules 
encircled by a discrete lymphoplasmacytic inflamma-
tory infiltrate. Extensive areas of tumor necrosis and 
hemorrhage were observed. The mass that covered the 
omentum in cat 1 (Figure 2C) and the mass covering 
the pancreas (Figure 2D) and lymph node in cat 2 pre-
sented neoplastic cell proliferation of epithelial origin 
similar to those observed in hepatic parenchyma. The 
microscopic lesions of both felines were compatible 
with the diagnosis of cholangiocarcinoma. 
For immunohistochemistry, tumor fragments 
from these two animals were embedded in paraffin and 
sent to the Vetmol laboratory, located in São Paulo, 
Brazil. Both cases had the same immunohistochemi-
cal profile regarding positive and negative tumor cell 
markers, from which it was possible to confirm the 
diagnosis of cholangiocarcinoma. The antibodies used 
and the results of each animal are summarized in Table 
1. Figure 3 are photomicrographs for both patients. To 
note, for the CK7 antibody, a new evaluation was per-
formed in the immunohistochemistry laboratory of the 
Federal Rural University of Rio de Janeiro, obtaining 
negative results for each patient.
DISCUSSION
The clinical signs of cats with hepatobiliary ne-
oplasms include apathy, lethargy, weakness, hyporexia, 
anorexia, weight loss, vomiting, diarrhea, polydipsia, asci-
tes, abdominal distention, jaundice, and dyspnea [2,5,6,8]. 
Cats with malignant neoplasms are more prone 
to show such clinical manifestations than felines with 
benign tumors [3]. The clinical observations seen in 
both patients with cholangiocarcinoma corroborate 
these previous findings.
Hematological and biochemical results indicated 
abnormal values and alterations in cats 1 and 2; however, 
any changes in blood exams of cats with bile duct neo-
plasm are not specific to hepatic tumors, given that some of 
these alterations may reflect only hepatocellular or biliary 
stasis [5]. The most common hematological alteration of 
felines with hepatobiliary neoplasm is leukocytosis. Serum 
biochemistry showed an increase in alanine aminotrans-
ferase, AST, and bilirubin, which are usually higher in 
cats with malignant hepatic tumors, but these alterations 
cannot be used as a differential diagnosis of benign hepatic 
neoplasm. There is also the occurrence of azotemia [3].
Cholangiocarcinoma usually occurs in older 
animals, with an average age of 9 years [3,5,8].  Occur-
rence in younger animals may be due to feline leukemia 
virus [6]. However, our patients tested negative for the 
virus. Thus, occurrence of cholangiocarcinoma in cats 
1 and 2 is possibly linked to the early and continuous 
exposure of carcinogens.
The biliary duct trematode Platynosomum fasto-
sum is considered a primary predisposing factor of chol-
angiocarcinoma in cats. P. fastosum was not observed in 
the two patients; although, the visualization of the adult 
parasite or its eggs by histopathological evaluation is not 
always possible. Another cause for the non-identification 
of the parasite could be that infections may have occurred 
in the past and thus have solved in the patients, although 
infections may cause chronic inflammation, which can 
culminate with e occurrence of the neoplasm [1,4].
Among other predisposing factors of cholan-
giocellular carcinoma are the chemical agents pluto-
nium and americium, intestinal parasites such as Ancy-
lostoma spp. and Trichuris vulpis, and the presence of 
chronic inflammation independent of the etiology, as 
long as they cause exacerbated proliferation of biliary 
duct epithelium cells [7,13].
Biliary duct carcinomas are firm, elevated, non-
-encapsulated, have a central umbilicated-like depres-
sion, and multiple whitish nodules [1,2,5-7], similar to 
that observed in cat 1. Evaluation of cat 2 revealed tumors 
with the same consistency, but presented as masses of 
large sizes, covering almost all the hepatic parenchyma.
In the microscopic examination, the morphologi-
cal findings led to the diagnosis of moderately differen-
tiated metastatic cholangiocarcinoma, with metastases in 
the omentum (cat 1) and in the pancreas and lymph node 
(cat 2). This metastatic potential of cholangiocarcinoma 
was already evidenced in another study [1,2,5-7].
4                                                                                                           M.P.B. Jardim, G.C. Cid, M.C. Oliveira, et al. 2019. Cholangiocarcinoma in Young Cats. 
                                                                                                                  Acta Scientiae Veterinariae. 47(Suppl 1): 394.
Figure 1. Hepatic parenchyma of two young felines with cholangiocarcinoma. A- Liver with nodules of whitish color, umbilicated, measuring up to 
3.0 cm in diameter, randomly distributed by the parenchyma. B- Masses of whitish coloring covering the hepatic parenchyma in the parietal face.
Figure 2. Diffuse proliferation of neoplastic cells of epithelial origin arranged in tubular form [HE; 63×obj.]. A- Microscopic analysis of cat 1. B- Mi-
croscopic analysis of cat 2. C- Neoplastic proliferation in the omentum of cat 1 (metastasis) [HE; 10×obj.]. D- Neoplastic proliferation in pancreas of 
cat 2 (metastasis) [HE; 20×obj.]
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Table 1. Immunohistochemical profile with markers for neoplastic cells and individual patient results.
Antibodies Clone Neoplastic cells  cat 1 Neoplastic cells  cat 2
CK Pan- Intermediate epithelial cell filaments AE1AE3 Positive Positive
CEA- Carcinoembryogenic antigen Polyclonal Positive Positive
CK7- Marker of ductal, glandular, superficial and 
transitional squamous epithelium OV-TL12/30 Negative Negative
CK20- Marker of gastric epithelium, intestinal 
urothelium Ks20.8 Negative Negative
TTF-1- Lung and thyroid carcinoma marker Polyclonal Negative Negative
Hepatocyte specific antigen OCH1E5 Negative Negative
CD10- Expressed in hepatocarcinomas and  
renal carcinomas 56C6 Negative Negative
CD56- Marker of neuroendocrine tumors BC56C04 Negative Negative
Figure 3. Immunohistochemical evaluation of two cats with biliary duct carcinoma. A- Positive marking for CK pan used to determine neoplastic cells in 
lymph node metastasis [10×obj.]. B- Positive marking for CEA in neoplastic cells and liver [40×obj.]. C- Negative marking for CD10 in liver [10×obj.]. 
D- Negative marking for CK7 in neoplastic cells and positive for internal control [40×obj.].
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Regarding immunohistochemistry, neoplastic 
cells were detected via the use of CK pan antibodies 
and CEA, such antibodies demonstrate immunoreacti-
vity for most cholangiocarcinoma. The CEA antibodies 
are considered the most important tumor markers in 
differentiating cholangiocarcinoma from hepatocellu-
lar carcinoma [8-10]. The negative results for the 
hepatocyte-specific antigen and CD10 are in agreement 
with the studies in which these have been established 
as sensitive markers for hepatocellular carcinoma, with 
little expression in cholangiocarcinoma [9]. 
For individual analysis of the CK7 antibody, a 
negative result was obtained for each patient. These data 
differed from those observed in previous studies, where 
the expression of CK7 from moderate to high sensitivity 
and specificity is described for most cholangiocarcinoma 
in dogs (77.8%) [12] and in humans (76%) [9]. Scarce 
works demonstrate the efficacy of CK7 antibody in cats, 
which suggests that the utility of this marker may be 
limited in felines as well as verified in this study.
According to the authors’ knowledge, this is 
the second report of cholangiocarcinoma in young cats, 
with only one study evidencing the presence of such 
neoplasia in a 4-year-old cat [2].
Clinical and anatomopathological observa-
tions made evident that these two young cats, with 
3-year-old, had metastatic cholangiocarcinoma. Thus, 
veterinary providers should be aware that this tumor 
type can occur in young animals and be mindful of 
means of prevention and/or recommended treatment 
of predisposing factors.
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